Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.340
-0.060 (-4.29%)
At close: Apr 24, 2026, 4:00 PM EDT
1.330
-0.010 (-0.75%)
After-hours: Apr 24, 2026, 7:30 PM EDT
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $21.2 million as of April 24, 2026. Its market cap has increased by 77.57% in one year.
Market Cap
21.20M
Enterprise Value
7.83M
1-Year Change
77.57%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $21.20M, a decrease of -73.30%. That is a compound annual growth rate of -26.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 21.20M | 24.21% |
| Dec 31, 2025 | 17.07M | 229.00% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 23.53M |
| Jasper Therapeutics | 23.47M |
| Lexaria Bioscience | 23.39M |
| Marker Therapeutics | 23.34M |
| OSR Holdings | 22.96M |
| Quince Therapeutics | 22.17M |
| Exicure | 22.12M |
| VYNE Therapeutics | 21.50M |